Login / Signup

Effectiveness of Sinopharm's BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave.

Jihane BelayachiAbdelkader MhayiHind MajidiElmostafa El FahimeRedouane Abouqal
Published in: Vaccines (2024)
BBIBP-CorV boosters are effective in increasing protection against the Omicron variant-related COVID-19 deaths and severe/critical hospitalizations. The protection is reduced with older age and higher risk factors. These findings emphasize the importance of targeted vaccination strategies for different demographic groups and underscore the protective benefits of the first booster BBIBP-CorV vaccine.
Keyphrases
  • coronavirus disease
  • sars cov
  • risk factors
  • early onset
  • randomized controlled trial
  • systematic review
  • physical activity
  • respiratory syndrome coronavirus
  • middle aged
  • community dwelling